Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses

Background: Glioblastoma (GBM), which has a poor prognosis, accounts for 31% of all cancers in the brain and central nervous system. There is a paucity of research on prognostic indicators associated with the tumor immune microenvironment in GBM patients. Accurate tools for risk assessment of GBM pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Shengda, Yang, Bin, Zhang, Tingbao, Wei, Wei, Li, Zhiqiang, Chen, Jincao, Li, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562700/
https://www.ncbi.nlm.nih.gov/pubmed/36230961
http://dx.doi.org/10.3390/cells11193000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562700/
https://www.ncbi.nlm.nih.gov/pubmed/36230961
http://dx.doi.org/10.3390/cells11193000

Ejemplares similares